Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Baloxavir · Xofluza, S-033447

Small molecule · Inhibitor of influenza virus polymerase acidic (PA) endonuclease · developed by Sportpharm Llc

Approved FDA
1 Registered trials

What is Baloxavir?

Baloxavir is an antiviral small molecule that inhibits the influenza virus polymerase acidic (PA) endonuclease, blocking viral RNA transcription. It is studied in influenza, including treatment of influenza-like illness and chemoprophylaxis in close contacts such as nursing home residents and staff.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Xofluza, S-033447
Drug type
Small molecule
Targets
influenza virus polymerase acidic (PA) endonuclease
Mechanism
Inhibitor of influenza virus polymerase acidic (PA) endonuclease
Pathways
viral RNA polymerase activity
Therapy area
Infectious disease
Developer
Sportpharm Llc
In trials of
IMDX
FDA status
Approved as Xofluza, NDA210854 · FDA label
UNII
4G86Y4JT3F

✅ FDA-approved uses

From the indications section of the FDA label (version of Apr 24, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT05012189 Phase 4 Influenza Unknown IMDX

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

InfluenzaInfluenza -Like IllnessInfluenza, Human

Sources

Updated Oct 18, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.